SOW
LXRX icon

State of Wyoming’s Lexicon Pharmaceuticals LXRX Stock Holding History

State of Wyoming’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
119,090
+108,311
+1,005% +$211K 0.03% 730
2026
Q1 		$16.8K Sell
10,779
-49,792
-82% -$72.4K ﹤0.01% 1690
2025
Q4 		$69.7K Buy
60,571
+52,045
+610% +$71.5K 0.01% 1434
2025
Q3 		$11.5K Buy
+8,526
New +$9.68K ﹤0.01% 1753

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Sessa Capital
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State of Wyoming's LXRX Position: Q2 2026 in Review

State of Wyoming increased its Lexicon Pharmaceuticals (LXRX) stake by 1,005% in Q2 2026, buying an estimated $211K and bringing the position to 119,090 shares worth $286K. The position accounts for 0.03% of the portfolio, ranked #730.

State of Wyoming first reported a position in LXRX in Q3 2025 and has held it in 4 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • State of Wyoming held 119,090 shares of Lexicon Pharmaceuticals worth $286K as of Q2 2026.
  • State of Wyoming bought 108,311 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $211K.
  • Lexicon Pharmaceuticals made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #730 holding.
  • State of Wyoming first reported a position in Lexicon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.